Greenstreet Yvonne's Form 4 filing
Alnylam Pharmaceuticals, Inc. (ALNY) · filed Nov 14, 2025
- Accession no.
- 0001735276-25-000120
- Filed
- Nov 14, 2025
- Trade date
- Nov 12-13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 23 non-derivative transactions and 3 derivative transactions. Open-market sales total $11.6M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Greenstreet YvonneCIK 0001446125 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Common Stock | MOption exerciseAcquired | +650 | $42.22 | +$27,443 | 66,059 | Direct | |
| Nov 12, 2025 | Common Stock | MOption exerciseAcquired | +15,000 | $119.13 | +$1,786,950 | 81,059 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −711 | $448.07 | −$318,577.77 | 80,348 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −2,132 | $449.15 | −$957,587.8 | 78,216 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −453 | $450.17 | −$203,927.01 | 77,763 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −1,255 | $451.16 | −$566,205.8 | 76,508 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −1,210 | $452.43 | −$547,440.3 | 75,298 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −1,069 | $453.52 | −$484,812.88 | 74,229 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −1,960 | $454.84 | −$891,486.4 | 72,269 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −3,406 | $455.56 | −$1,551,637.36 | 68,863 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −2,420 | $456.64 | −$1,105,068.8 | 66,443 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −604 | $457.71 | −$276,456.84 | 65,839 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −430 | $458.42 | −$197,120.6 | 65,409 | Direct | |
| Nov 13, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $119.13 | +$1,191,300 | 75,409 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −654 | $447.73 | −$292,815.42 | 74,755 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −1,013 | $448.76 | −$454,593.88 | 73,742 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −1,477 | $450.02 | −$664,679.54 | 72,265 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −2,218 | $450.69 | −$999,630.42 | 70,047 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −1,702 | $451.94 | −$769,201.88 | 68,345 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −1,599 | $452.85 | −$724,107.15 | 66,746 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −881 | $453.99 | −$399,965.19 | 65,865 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −195 | $454.69 | −$88,664.55 | 65,670 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −261 | $456.03 | −$119,023.83 | 65,409 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Common Stock | MOption exerciseDisposed | −650 | $0.00 | $0 | 0 | Direct | |
| Nov 12, 2025 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 10,000 | Direct | |
| Nov 13, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.